Associations of Physical Activity Levels with Depressive Symptoms among Patients with Radiographic Axial Spondyloarthritis: A Cross-Sectional Study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42457341.
- Also identified by DOI 10.3899/jrheum.2026-0065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to examine the associations between physical activity (PA) levels and depressive symptoms in patients with radiographic axial spondyloarthritis (r-axSpA). We conducted a cross-sectional analysis of patients with r-axSpA identified from the UK Biobank. Total physical activity (TPA) was assessed using a modified version of the short-form International Physical Activity Questionnaire (IPAQ-SF), and leisure-time physical activity (LTPA) was derived from self-reported frequency and duration of five leisure activities during the preceding four weeks. Depressive symptoms were assessed using the Patient Health Questionnaire-2 (PHQ-2). Multivariable logistic regression models were used to examine the associations between PA levels and depressive symptoms. Among 1542 patients with r-axSpA, those engaging in moderate-level PA had the lowest prevalence of depressive symptoms. After full adjustment, moderate-level TPA was associated with lower odds of depressive symptoms compared with low-level TPA (OR 0.55; 95% CI 0.36-0.82), whereas the association for high-level TPA was not statistically significant (OR 0.63; 95% CI 0.39-1.01). Moderate-level LTPA was also associated with lower odds of depressive symptoms (OR 0.58; 95% CI 0.34-0.996), while low- and high-level LTPA showed no significant associations after full adjustment. Moderate-level PA was associated with a lower prevalence of depressive symptoms in patients with r-axSpA, whereas associations for high-level PA were less consistent. Our findings suggest that PA levels may be an important correlate of depressive symptoms in patients with r-axSpA, warranting confirmation in longitudinal studies.